Overview

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to develop new ways of imaging fatty blockages in the leg arteries to improve upon techniques used now and to develop new ways of understanding how new treatments may affect the disease.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Virginia
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Treatments:
Ezetimibe
Simvastatin
Criteria
Inclusion Criteria:

Patients age 30-85 referred to the vascular imaging laboratory with documented evidence of
peripheral arterial disease (0.4
Exclusion Criteria:

Age<30, >85

GFR less than 45mL/min based on a serum creatinine drawn within 90 days of the MRI:

Pregnancy Contraindications to a magnetic resonance examination

- Intracranial clips

- Implantable pacemaker and defibrillator

- Cochlear or intraocular implants

- Claustrophobia

- Any metallic implant not listed as magnetic resonance compatible in Shellock F.G
---Pocket Guide to Magnetic Resonance Procedures and Metallic Objects, Update 2000.
Lippincott, Williams and Wilkins